Biotech

All Articles

Roche discards $120M tau possibility, coming back legal rights to UCB

.Roche has actually come back the civil rights to UCB's anti-tau antibody bepranemab, leaving a $120...

Editas builds up in vivo method through $238M Genenvant deal

.Editas Medicines has actually signed a $238 thousand biobucks treaty to integrate Genevant Scientif...

Combo results, Vicodin miss out on as well as celestial safety

.Vertex has actually mentioned phase 3 information on its near-approval ache medication candidate su...

Angelini markers $360M biobucks deal for ph. 1 brain disorder medicine

.Italy's Angelini Pharma has actually authorized a $360 million biobucks treaty fixated a period 1-s...

Sage lays off half of R&ampD group and also shocks C-suite once again

.Sage Rehabs' newest effort to shrink its own pipe as well as labor force will observe a third of th...

With phase 1 information, Aura possesses an eye on early-stage bladder cancer

.With its own lead candidate in a period 3 test for a rare eye cancer cells, Aura Biosciences is loo...

Less than a year in, BenevolentAI CEO is actually out-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of significant management hirings, firings and ...

Roche MAGE-A4 test withdrawn after important assessment

.Roche has produced yet another MAGE-A4 plan vanish, removing a period 1 test of a T-cell bispecific...

FDA puts partial hang on BioNTech-OncoC4 period 3 trial

.The FDA has actually implemented a partial hang on a period 3 non-small cell lung cancer trial run ...

REGiMMUNE, Kiji merge to develop Treg 'super business,' planning IPO

.Taiwan's REGiMMUNE and Europe-based Kiji Rehabs are actually merging to create an internationally m...